IP Library Granted Patent US 9,850,495
Granted Patent B2
US 9,850,495 · App. 14/384,695 · Granted Dec 26, 2017

Nucleotide sequences encoding fasciated EAR4 (FEA4) and methods of use thereof

Inventors: Stephen M Allen (Wilmington, DE); David Peter Jackson (New York, NY); Mai Komatsu (Wilmington, DE); Michael Pautler (Cold Spring Harbor, NY); Hajime Sakai (Newark, DE); Erik Vollbrecht (Ames, IA); Rebecca Weeks (Ames, IA)
Assignees: E. I. du Pont de Nemours And Company; Cold Spring Harbor Laboratory; Iowa State University Research Foundation, Inc.
C12N15/8261A01H5/10C07K14/415C12N15/8216C12N15/8229C12Q1/6895C12Q2600/13C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,850,495
App. No.
14/384,695
Granted
Dec 26, 2017
Kind
B2
Abstract

Methods and compositions for modulating shoot apical meristem size are provided. Methods are provided for modulating the expression of Fea4 sequence in a host plant or plant cell to modulate agronomic characteristics such as altered size and number of organs, including plant seeds.

Claims (6)

1. A method of making a maize plant in which expression of an endogenous FEA4 gene, which encodes a polypeptide having an amino acid sequence of at least 98% identity, based on the Clustal W method of alignment, when compared to SEQ ID NO: 3, is reduced relative to a control maize plant, the method comprising the steps of:

a. introducing a mutation into the endogenous FEA4 gene; and

b. detecting the mutation and wherein the maize plant comprising the mutant FEA4 gene has reduced plant height, increased kernel rows, and altered tassel branching, as compared to a wild type maize plant.

2. The method of claim 1 wherein steps (a) and (b) are done using a Targeting Induced Local Lesions IN Genomics (TILLING) method and wherein the mutation is effective in reducing the expression of the endogenous Fea4 gene or its activity.

3. The method of claim 1 wherein the mutation is a site-specific mutation.

4. The method of claim 1 , wherein the mutation comprises a transposon inserted into the FEA4 gene sequence.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 29, 2022
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: CORTEVA AGRISCIENCE LLC
Reel/Frame 063141/0155 →
Continuity (3)
Provisional Application 61610730 · Mar 14, 2012
Provisional Application 61759342 · Jan 31, 2013
Related Publication 20150033415A1 · Jan 29, 2015